A study of patients with moderate or severe plaque psoriasis presented at the European Academy of Dermatology and Venereology Congress in Paris reported that overall, 64% of patients had one or more comorbid conditions at the start of treatment, and some of the patients had new comorbid diagnoses during follow-up. The proportion of patients who achieved disease clearance decreased as the number of comorbidities increased.